Johnson & Johnson said on Monday it was expecting to retain a stake of about 9.5% in its newly separated consumer health unit, Kenvue, after completing a share exchange offer.
Shares of the consumer health company rose 1.4% in premarket trading.
J&J launched the exchange offer last month under which its stockholders could opt for shares of the former consumer health unit related to the spinoff.
Source : Reuters
The sharp rise in long-term interest rates since 2020 is difficult to explain from slow-moving…
Trade wars do not simply redirect exports; they also reshape the costs of production, disrupt…
Few features of modern work are as widely criticised as meetings. Using data from over…
Forecasts of AI-driven job destruction rest on counting automatable tasks. But labour markets hire, pay,…
US federal government debt exceeded $40 trillion in August 2026, triggering concerns about fiscal credibility…
Global current account imbalances are widening again. This column argues that currency undervaluation, supported by…